Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Research Report 2020

This report focuses on Non-steroidal Anti-inflammatory Drugs (NSAID) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-steroidal Anti-inflammatory Drugs (NSAID) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

    Bayer

    Ecotrin

    Generic

    St. Joseph

    Elanco

    Zoetis

    Boehringer Ingelheim

    Merial

    Merck Animal Health

    North America

    Europe

    China

    Japan

    Salicylates

    Propionic acid derivatives

    Acetic acid derivatives

    Enolic acid (Oxicam) derivatives

    Anthranilic acid derivatives (Fenamates)

    Selective COX-2 inhibitors (Coxibs)

    Sulfonanilides

    Human

    Animals

    Others

Table of Contents

1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)

1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Type

1.2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Salicylates

1.2.3 Propionic acid derivatives

1.2.4 Acetic acid derivatives

1.2.5 Enolic acid (Oxicam) derivatives

1.2.6 Anthranilic acid derivatives (Fenamates)

1.2.7 Selective COX-2 inhibitors (Coxibs)

1.2.8 Sulfonanilides

1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Segment by Application

1.3.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Comparison by Application: 2020 VS 2026

1.3.2 Human

1.3.3 Animals

1.3.4 Others

1.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Estimates and Forecasts

1.4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue 2015-2026

1.4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales 2015-2026

1.4.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Region: 2020 Versus 2026

2.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Manufacturers (2015-2020)

2.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015-2020)

2.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price by Manufacturers (2015-2020)

2.4 Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturing Sites, Area Served, Product Type

2.5 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Competitive Situation and Trends

2.5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key Non-steroidal Anti-inflammatory Drugs (NSAID) Players (Opinion Leaders)

3.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.3.1 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.3.2 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.4.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.4.2 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Region

3.5.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region

3.5.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.6.1 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.6.2 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Facts & Figures by Country

3.7.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.7.2 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type (2015-2020)

4.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Type (2015-2020)

4.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price Market Share by Type (2015-2020)

4.4 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2015-2020)

5.2 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Application (2015-2020)

5.3 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price by Application (2015-2020)

6.1 Bayer

6.1.1 Corporation Information

6.1.2 Bayer Description, Business Overview and Total Revenue

6.1.3 Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Bayer Products Offered

6.1.5 Bayer Recent Development

6.2 Ecotrin

6.2.1 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.2.2 Ecotrin Description, Business Overview and Total Revenue

6.2.3 Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.2.4 Ecotrin Products Offered

6.2.5 Ecotrin Recent Development

6.3 Generic

6.3.1 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.3.2 Generic Description, Business Overview and Total Revenue

6.3.3 Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.3.4 Generic Products Offered

6.3.5 Generic Recent Development

6.4 St. Joseph

6.4.1 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.4.2 St. Joseph Description, Business Overview and Total Revenue

6.4.3 St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.4.4 St. Joseph Products Offered

6.4.5 St. Joseph Recent Development

6.5 Elanco

6.5.1 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.5.2 Elanco Description, Business Overview and Total Revenue

6.5.3 Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.5.4 Elanco Products Offered

6.5.5 Elanco Recent Development

6.6 Zoetis

6.6.1 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.6.2 Zoetis Description, Business Overview and Total Revenue

6.6.3 Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.6.4 Zoetis Products Offered

6.6.5 Zoetis Recent Development

6.7 Boehringer Ingelheim

6.6.1 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.6.2 Boehringer Ingelheim Description, Business Overview and Total Revenue

6.6.3 Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Boehringer Ingelheim Products Offered

6.7.5 Boehringer Ingelheim Recent Development

6.8 Merial

6.8.1 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.8.2 Merial Description, Business Overview and Total Revenue

6.8.3 Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.8.4 Merial Products Offered

6.8.5 Merial Recent Development

6.9 Merck Animal Health

6.9.1 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Production Sites and Area Served

6.9.2 Merck Animal Health Description, Business Overview and Total Revenue

6.9.3 Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Gross Margin (2015-2020)

6.9.4 Merck Animal Health Products Offered

6.9.5 Merck Animal Health Recent Development

7.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

7.4 Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis

8.1 Marketing Channel

8.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List

8.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Customers

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

10.1 Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2021-2026)

10.1.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2021-2026)

10.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2021-2026)

10.2.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2021-2026)

10.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2021-2026)

10.3.2 Global Forecasted Revenue of Non-steroidal Anti-inflammatory Drugs (NSAID) by Region (2021-2026)

10.4 North America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

10.5 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

10.6 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

10.7 Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

10.8 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Estimates and Projections (2021-2026)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Growth Rate Comparison by Type (2015-2026)

    Table 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Comparison by Application: 2020 VS 2026

    Table 3. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)

    Table 4. Global Key Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Covered in This Study

    Table 5. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Manufacturers (2015-2020)

    Table 6. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2015-2020)

    Table 7. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million USD) by Manufacturers (2015-2020)

    Table 8. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015-2020)

    Table 9. Global Market Non-steroidal Anti-inflammatory Drugs (NSAID) Average Price (USD/Unit) of Key Manufacturers (2015-2020)

    Table 10. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Sites and Area Served

    Table 11. Manufacturers Non-steroidal Anti-inflammatory Drugs (NSAID) Product Types

    Table 12. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global Non-steroidal Anti-inflammatory Drugs (NSAID) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-steroidal Anti-inflammatory Drugs (NSAID) as of 2019)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Main Points Interviewed from Key Non-steroidal Anti-inflammatory Drugs (NSAID) Players

    Table 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Region (2015-2020)

    Table 17. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2015-2020)

    Table 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) by Region (2015-2020)

    Table 19. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2015-2020)

    Table 20. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2015-2020) (K Units)

    Table 21. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2015-2020)

    Table 22. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2015-2020) (US$ Million)

    Table 23. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2015-2020)

    Table 24. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2015-2020) (K Units)

    Table 25. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2015-2020)

    Table 26. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2015-2020) (US$ Million)

    Table 27. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2015-2020)

    Table 28. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Region (2015-2020) (K Units)

    Table 29. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2015-2020)

    Table 30. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Region (2015-2020) (US$ Million)

    Table 31. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2015-2020)

    Table 32. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2015-2020) (K Units)

    Table 33. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2015-2020)

    Table 34. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2015-2020) (US$ Million)

    Table 35. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2015-2020)

    Table 36. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales by Country (2015-2020) (K Units)

    Table 37. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country (2015-2020)

    Table 38. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Country (2015-2020) (US$ Million)

    Table 39. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country (2015-2020)

    Table 40. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Type (2015-2020)

    Table 41. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2015-2020)

    Table 42. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) by Type (2015-2020)

    Table 43. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2015-2020)

    Table 44. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Price (USD/Unit) by Type (2015-2020)

    Table 45. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) by Application (2015-2020)

    Table 46. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2015-2020)

    Table 47. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2015-2020)

    Table 48. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 49. Bayer Description and Business Overview

    Table 50. Bayer Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 51. Bayer Main Product

    Table 52. Bayer Recent Development

    Table 53. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 54. Ecotrin Corporation Information

    Table 55. Ecotrin Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 56. Ecotrin Main Product

    Table 57. Ecotrin Recent Development

    Table 58. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 59. Generic Corporation Information

    Table 60. Generic Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 61. Generic Main Product

    Table 62. Generic Recent Development

    Table 63. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 64. St. Joseph Corporation Information

    Table 65. St. Joseph Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 66. St. Joseph Main Product

    Table 67. St. Joseph Recent Development

    Table 68. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 69. Elanco Corporation Information

    Table 70. Elanco Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 71. Elanco Main Product

    Table 72. Elanco Recent Development

    Table 73. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 74. Zoetis Corporation Information

    Table 75. Zoetis Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 76. Zoetis Main Product

    Table 77. Zoetis Recent Development

    Table 78. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 79. Boehringer Ingelheim Corporation Information

    Table 80. Boehringer Ingelheim Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 81. Boehringer Ingelheim Main Product

    Table 82. Boehringer Ingelheim Recent Development

    Table 83. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 84. Merial Corporation Information

    Table 85. Merial Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 86. Merial Main Product

    Table 87. Merial Recent Development

    Table 88. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Corporation Information

    Table 89. Merck Animal Health Corporation Information

    Table 90. Merck Animal Health Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)

    Table 91. Merck Animal Health Main Product

    Table 92. Merck Animal Health Recent Development

    Table 93. Sales Base and Market Concentration Rate of Raw Material

    Table 94. Key Suppliers of Raw Materials

    Table 95. Non-steroidal Anti-inflammatory Drugs (NSAID) Distributors List

    Table 96. Non-steroidal Anti-inflammatory Drugs (NSAID) Customers List

    Table 97. Market Key Trends

    Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 99. Key Challenges

    Table 100. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Forecast by Type (2021-2026)

    Table 101. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Type (2021-2026)

    Table 102. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) Forecast by Type (2021-2026)

    Table 103. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) Market Share Forecast by Type (2021-2026)

    Table 104. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Forecast by Application (2021-2026)

    Table 105. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) Forecast by Application (2021-2026)

    Table 106. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) Forecast by Region (2021-2026)

    Table 107. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share Forecast by Region (2021-2026)

    Table 108. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 109. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share Forecast by Region (2021-2026)

    Table 110. Research Programs/Design for This Report

    Table 111. Key Data Information from Secondary Sources

    Table 112. Key Data Information from Primary Sources

List of Figures

    Figure 1. Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)

    Figure 2. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Type: 2020 VS 2026

    Figure 3. Salicylates Product Picture

    Figure 4. Propionic acid derivatives Product Picture

    Figure 5. Acetic acid derivatives Product Picture

    Figure 6. Enolic acid (Oxicam) derivatives Product Picture

    Figure 7. Anthranilic acid derivatives (Fenamates) Product Picture

    Figure 8. Selective COX-2 inhibitors (Coxibs) Product Picture

    Figure 9. Sulfonanilides Product Picture

    Figure 10. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Share by Application: 2020 VS 2026

    Figure 11. Human

    Figure 12. Animals

    Figure 13. Others

    Figure 14. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size 2015-2026 (US$ Million)

    Figure 15. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Capacity (K Units) (2015-2026)

    Figure 16. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size Market Share by Region: 2020 Versus 2026

    Figure 17. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers in 2020

    Figure 18. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers in 2019

    Figure 19. The Global 5 and 10 Largest Players: Market Share by Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue in 2019

    Figure 20. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 21. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region (2015-2020)

    Figure 22. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region in 2019

    Figure 23. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region (2015-2020)

    Figure 24. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in 2019

    Figure 25. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2019

    Figure 26. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2019

    Figure 27. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 28. U.S. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 29. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 30. Canada Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 31. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2019

    Figure 32. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2019

    Figure 33. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 34. Germany Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 35. France Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 36. France Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 37. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 38. U.K. Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 39. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 40. Italy Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 41. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 42. Russia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 43. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Region in 2019

    Figure 44. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Region in 2019

    Figure 45. China Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 46. China Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 47. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 48. Japan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 49. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 50. South Korea Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 51. India Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 52. India Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 53. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 54. Australia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 55. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 56. Taiwan Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 57. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 58. Indonesia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 59. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 60. Thailand Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 61. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 62. Malaysia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 63. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 64. Philippines Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 65. Vietnam Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 66. Vietnam Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 67. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2019

    Figure 68. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2019

    Figure 69. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 70. Mexico Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 71. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 72. Brazil Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 73. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 74. Argentina Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 75. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Country in 2019

    Figure 76. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Market Share by Country in 2019

    Figure 77. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 78. Turkey Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 79. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 80. Saudi Arabia Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 81. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate (2015-2020) (K Units)

    Figure 82. U.A.E Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 83. Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2015-2020)

    Figure 84. Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2019

    Figure 85. Revenue Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2015-2020)

    Figure 86. Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2019

    Figure 87. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth by Type (2015-2020) (K Units)

    Figure 88. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application (2015-2020)

    Figure 89. Global Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Share by Application in 2019

    Figure 90. Global Revenue Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2015-2020)

    Figure 91. Global Revenue Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2020

    Figure 92. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 93. Ecotrin Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 94. Generic Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 95. St. Joseph Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 96. Elanco Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 97. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 98. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 99. Merial Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 100. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 101. Price Trend of Key Raw Materials

    Figure 102. Manufacturing Cost Structure of Non-steroidal Anti-inflammatory Drugs (NSAID)

    Figure 103. Manufacturing Process Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID)

    Figure 104. Non-steroidal Anti-inflammatory Drugs (NSAID) Industrial Chain Analysis

    Figure 105. Channels of Distribution

    Figure 106. Distributors Profiles

    Figure 107. Porter's Five Forces Analysis

    Figure 108. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) and Growth Rate Forecast (2021-2026)

    Figure 109. North America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 110. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) and Growth Rate Forecast (2021-2026)

    Figure 111. Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 112. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) and Growth Rate Forecast (2021-2026)

    Figure 113. Latin America Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 114. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) and Growth Rate Forecast (2021-2026)

    Figure 115. Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 116. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Sales (K Units) and Growth Rate Forecast (2021-2026)

    Figure 117. Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 118. Bottom-up and Top-down Approaches for This Report

    Figure 119. Data Triangulation

    Figure 120. Key Executives Interviewed